Frontiers in Immunology (Dec 2024)
Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification
Abstract
No abstracts available.Keywords
Frontiers in Immunology (Dec 2024)